A selective oestrogen receptor modulator (SERM) called raloxifene (Ralista (60mg)) is given to postmenopausal women to treat and prevent osteoporosis. try raloxifene 60 mg tablet
In postmenopausal women with osteoporosis and those with a high risk of developing invasive breast cancer, it is also used to lower that risk. Both bone density and bone turnover are reduced.
consequences of ralista (60mg)
Significant negative effects: Stroke, pulmonary embolism, and deep vein thrombosis (clotting in the deep veins).
Heat flushes, leg cramps, sweating, insomnia, peripheral edoema, vaginal bleeding, flu-like symptoms, rashes, and headaches are the most frequent symptoms.
Gastrointestinal: GI problems, nausea, vomiting, and diarrhoea.
Gaining weight is metabolic.
Musculoskeletal: Tendon problem, joint inflammation, muscular soreness, and pain in the joints.
In postmenopausal women with osteoporosis and those with a high risk of developing invasive breast cancer, it is also used to lower that risk. Both bone density and bone turnover are reduced.
consequences of ralista (60mg)
Significant negative effects: Stroke, pulmonary embolism, and deep vein thrombosis (clotting in the deep veins).
Heat flushes, leg cramps, sweating, insomnia, peripheral edoema, vaginal bleeding, flu-like symptoms, rashes, and headaches are the most frequent symptoms.
Gastrointestinal: GI problems, nausea, vomiting, and diarrhoea.
Gaining weight is metabolic.
Musculoskeletal: Tendon problem, joint inflammation, muscular soreness, and pain in the joints.
0